Home > Insider Trading > Filing (0001104659-14-000347)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1463729	Receptos Inc.	RCPT	Pharmaceutical Preparations (2834)	264190792

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1205903	H William Rastetter	C/O Receptos, Inc. 10835 Road To The Cure, Suite 205 San Diego CA 92121		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2014-01-02	27,581	$30.29	1,305,180	No	4	S	Indirect	By Funds

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Funds

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	332,234	Indirect	By Trust

Footnotes

Disposition of shares by the Venrock entities. Beneficial ownership by the Venrock entities consists of: (i) 1,177,667 shares of common stock held by Venrock Associates V, L.P. ("Venrock Associates"); (ii) 99,845 shares of common stock held by Venrock Partners V, L.P. ("Venrock Partners"); and (iii) 27,668 shares of common stock held by Venrock Entrepreneurs Fund V, L.P. ("Venrock Entrepreneurs").
The sole general partner of Venrock Associates is Venrock Management V, LLC ("VM5"). The sole general partner of Venrock Partners is Venrock Partners Management V, LLC ("VPM5"). The sole general partner of Venrock Entrepreneurs is VEF Management V, LLC ("VEF"). VM5, VPM5 and VEF disclaim beneficial ownership over all shares held by Venrock Associates, Venrock Partners and Venrock Entrepreneurs, except to the extent of their indirect pecuniary interest therein. Dr. Rastetter was formerly a consultant of an entity affiliated with the Venrock entities but does not have voting or investment control over the shares held by the Venrock entities. Dr. Rastetter has an indirect pecuniary interest in the investment held by the Venrock entities and expressly disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein.